Bearing in mind the objective of contributing to deep knowledge on a panel of cancer-related genes (TP53, CCND1, FUS, YBX1, PTBP1, c-MYC and PKM2) in FMCs and its relation with clinicopathological parameters. This evidence concerns the gene FUS and cancer.